Consumer preferences for the development of new emulsion products based on vegetable and animal fats. [PDF]
Kowalska M +5 more
europepmc +1 more source
Essays in Pharmaceutical Economics
This doctoral dissertation incorporates formal industrial organization and mechanism design analysis in the pharmaceutical industry in order to expand our understanding of modern pharmaceutical markets and provide new insights to key policy questions. The focus is primarily on the supply side of the pharmaceutical sector and in particular on questions ...
openaire +1 more source
Politicised Changes to the NICE Threshold Risk Making Cost-Effectiveness Analysis Performative, Not Informative. [PDF]
Vallejo-Torres L +7 more
europepmc +1 more source
Education as an upstream social security intervention: constructing a competency-based talent development framework in health economics. [PDF]
Luo H, Li A, Hua H.
europepmc +1 more source
TRIPS, pharmaceutical patents, and generic competition in India. [PDF]
Kyle MK, Sampat BN, Shadlen KC.
europepmc +1 more source
Pharmacy Benefit Manager Market Concentration for Prescriptions Filled at Retail Pharmacies by State and Payer Type. [PDF]
Qato DM, Chen Y, Van Nuys K.
europepmc +1 more source
Bo Ding,1 Run Zhao,2 Xinyi Yue,2 Dexun Li2 1Pharmacy Department, Hefei Maternal and Child Health Hospital, Hefei, People’s Republic of China; 2School of Pharmaceutical Economics and Management, Anhui University of Chinese Medicine, Hefei, People’s ...
Ding B, Zhao R, Yue X, Li D
doaj
Unlocking potential: Development finance reforms needed to support localized health product manufacturing. [PDF]
Lynch S +4 more
europepmc +1 more source
Economic Markets and Pharmaceutical Innovation
Pharmaceutical innovations reach the market after a long and risky process that requires large, fixed, and sunk investments. Governments provide incentives for firms to make these investments through various forms of intellectual property protection that attempt to provide a return on capital for investors.
openaire +1 more source
Global mechanisms to improve affordability of high-priced medicines: the role of the WHO model lists of essential medicines. [PDF]
Jenei K.
europepmc +1 more source

